145 related articles for article (PubMed ID: 4998498)
1. Influence of V.D.S. (diffusible killed antitubercular vaccine Salvioli) on the course of experimental tuberculosis in guinea-pigs evoked by H 37 Rv strain bacilli.
Fafrowicz B; Szmygin J
Clin Pediatr (Bologna); 1970 Jul; 52(7):299-302. PubMed ID: 4998498
[No Abstract] [Full Text] [Related]
2. [Influence of Bacillus subtilis on the course of experimental tuberculosis in guinea pigs evoked by the strain of drug-resistant bacilli].
Fafrowicz B
Ann Acad Med Stetin; 1969; 15():345-76. PubMed ID: 4985053
[No Abstract] [Full Text] [Related]
3. Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens.
Brodin P; Majlessi L; Brosch R; Smith D; Bancroft G; Clark S; Williams A; Leclerc C; Cole ST
J Infect Dis; 2004 Jul; 190(1):115-22. PubMed ID: 15195250
[TBL] [Abstract][Full Text] [Related]
4. The influence of VDS on the course of experimentaluberculosis in guinea-pigs provoked by the strain of drug-resistant bacilli.
Fafrowicz B; Dominiczak K
Clin Pediatr (Bologna); 1968 Jul; 50(7):373-8. PubMed ID: 5745552
[No Abstract] [Full Text] [Related]
5. Protective efficacy of recombinant (Ag85A) BCG Tokyo with Ag85A peptide boosting against Mycobacterium tuberculosis-infected guinea pigs in comparison with that of DNA vaccine encoding Ag85A.
Sugawara I; Udagawa T; Taniyama T
Tuberculosis (Edinb); 2007 Mar; 87(2):94-101. PubMed ID: 16815096
[TBL] [Abstract][Full Text] [Related]
6. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
7. The contribution of hydrogen peroxide resistance to virulence of Mycobacterium tuberculosis during the first six days after intravenous infection of normal and BCG-vaccinated guinea-pigs.
Jackett PS; Aber VR; Mitchison DA; Lowrie DB
Br J Exp Pathol; 1981 Feb; 62(1):34-40. PubMed ID: 6784743
[TBL] [Abstract][Full Text] [Related]
8. [The virulence of resistance strains of Mycobacterium tuberculosis for guinea pigs and experimental therapeutic effects of antitubercular agents on the animals infected by the resistant strains. II. Experimental therapeutic effect on guinea pigs infected by resistant strains of Mycobacterium tuberculosis].
Yan BS
Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1982 Aug; 5(4):206-8. PubMed ID: 6816558
[No Abstract] [Full Text] [Related]
9. [Experimental study on the evaluation of BCG-immunity in guinea pigs by airborne infection (supplemental study)].
Toyohara M; Shimoide H
Kekkaku; 1969 Jan; 44(1):7-11. PubMed ID: 4976218
[No Abstract] [Full Text] [Related]
10. [The virulence of resistant strains of Mycobacterium tuberculosis for guinea pigs and experimental therapeutic effects of antitubercular agents on the animals infected by the resistant strains. I. The virulence of the resistant strains of Mycobacterium tuberculosis].
Wang XG
Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1982 Aug; 5(4):204-6. PubMed ID: 6816557
[No Abstract] [Full Text] [Related]
11. The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium.
de Lisle GW; Wards BJ; Buddle BM; Collins DM
Tuberculosis (Edinb); 2005; 85(1-2):73-9. PubMed ID: 15687030
[TBL] [Abstract][Full Text] [Related]
12. [Immunogenic properties of Mycobacterium tuberculosis resistant to various tuberculostatic agents. Experimental study].
Djurisić M; Drndarski K; Nesković V
Glas Srp Akad Nauka Med; 1965; (18):69-74. PubMed ID: 4956328
[No Abstract] [Full Text] [Related]
13. Comparison of the protective efficacy of bacille calmette-Guérin vaccination against aerosol challenge with Mycobacterium tuberculosis and Mycobacterium bovis.
Williams A; Davies A; Marsh PD; Chambers MA; Hewinson RG
Clin Infect Dis; 2000 Jun; 30 Suppl 3():S299-301. PubMed ID: 10875804
[TBL] [Abstract][Full Text] [Related]
14. Vaccine-induced cytokine responses in a guinea pig model of pulmonary tuberculosis.
McMurray DN; Allen SS; Jeevan A; Lasco T; Cho H; Skwor T; Yamamoto T; McFarland C; Yoshimura T
Tuberculosis (Edinb); 2005; 85(5-6):295-301. PubMed ID: 16253558
[TBL] [Abstract][Full Text] [Related]
15. [The biological properties and virulence of a lysogenic strain from an SM-resistant strain of Mycobacterium tuberculosis].
Nakano H; Sushida K
Kekkaku; 1985 Nov; 60(11):577-84. PubMed ID: 3937930
[No Abstract] [Full Text] [Related]
16. Diffusible killed antitubercular vaccine (V.D.S.). Results obtained in the first years of V.D.S. application.
Salvioli G
Panminerva Med; 1968; 10(1):1-10. PubMed ID: 5657294
[No Abstract] [Full Text] [Related]
17. Mechanisms of vaccine-induced resistance in a guinea pig model of pulmonary tuberculosis.
McMurray DN; Dai G; Phalen S
Tuber Lung Dis; 1999; 79(4):261-6. PubMed ID: 10692995
[No Abstract] [Full Text] [Related]
18. The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs.
Martin C; Williams A; Hernandez-Pando R; Cardona PJ; Gormley E; Bordat Y; Soto CY; Clark SO; Hatch GJ; Aguilar D; Ausina V; Gicquel B
Vaccine; 2006 Apr; 24(17):3408-19. PubMed ID: 16564606
[TBL] [Abstract][Full Text] [Related]
19. [A new vaccine strain: MPH (Murine Praha Homogeneous), developed from Mycobacterium microti OV 247 (Wells)].
Sula I
Tuberkuloza; 1966; 18(1-3):275-8. PubMed ID: 16296096
[No Abstract] [Full Text] [Related]
20. Latent tuberculosis: models, mechanisms, and novel prospects for eradication.
Riska PF; Carleton S
Semin Pediatr Infect Dis; 2002 Oct; 13(4):263-72. PubMed ID: 12491232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
